IPCA Laboratories Limited has informed the Exchange regarding a press release dated March 27, 2024, titled "Press Release w.r.t Technology Transfer to Omexa Formulary Pvt. Ltd. for development of an anti-cancer biosimilar for global market".
IPCA Laboratories Limited has informed the Exchange regarding a press release dated March 27, 2024, titled "Press Release w.r.t Technology Transfer to Omexa Formulary Pvt. Ltd. for development of an anti-cancer biosimilar for global market".